Latest news with #bullish
Yahoo
4 hours ago
- Business
- Yahoo
Netflix Stock Ready to Move Back Toward Record Peak
Netflix Inc (NASDAQ:NFLX) stock was last seen down 0.9% at $1,165.72, trading at its lowest level since May 15 and on track for its third-straight daily loss, as well as its fourth consecutive week in the red. The security is up 30.8% in 2025, however, and sports an even healthier 83.4% year-over-year lead. Even better, a historically bullish trendline could soon help the shares move closer to their June 30, record high of $1,341.15. Per Schaeffer's Senior Quantitative Analyst Rocky White, NFLX's recent pullback placed it within one standard deviation of its 80-day moving average. Shares were above this trendline in at least eight of the last 10 trading days, and spent 80% of the past two months above it. Within these parameters, eight other signals occurred over the past three years, after which the stock was higher one month later 88% of the time, averaging a 12.2% gain. Should similar move happen, shares would land at $1,307.93 -- just shy of their record peak. An unwinding of pessimism in the options pits could create additional headwinds. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), NFLX's 50-day put/call volume ratio sits higher than 96% of annual readings. Options look affordably priced, making this an ideal time to bet on next moves. This is per its Schaeffer's Volatility Index (SVI) of 27%, which stands in the 7th percentile of readings from the past year, suggesting options traders are pricing in low volatility expectations. Sign in to access your portfolio
Yahoo
5 hours ago
- Business
- Yahoo
The Australian Dollar Is Heating Up. Should You Buy It Here?
September Australian dollar futures (A6U25) present a buying opportunity on more price strength. See on the daily bar chart for the September Australian dollar futures that prices are trending higher and have just hit a nine-month high after producing a bullish upside breakout from the recent trading range. See, too, at the bottom of the chart that the moving average convergence divergence (MACD) indicator has just produced a bullish line crossover signal, whereby the red MACD line crossed above the blue trigger line. The bulls are in firm technical control. More News from Barchart NVDA Broken Wing Butterfly Trade Targets A Profit Zone Between 150 and 160 Is Opendoor Stock a Buy at New 52-Week Highs? Billionaire Peter Thiel is Betting Big on Stablecoins. Should You Buy the "MicroStrategy of Ethereum," Too? Stop Missing Market Moves: Get the FREE Barchart Brief – your midday dose of stock movers, trending sectors, and actionable trade ideas, delivered right to your inbox. Sign Up Now! Fundamentally, the commodity-export-driven Australian economy is healthy. Australia generally has a strong and resilient economy, seeing consistent growth, a diversified workforce, and a high level of economic freedom. A move in the September Aussie dollar above chart resistance at this week's high of .6631 would become a buying opportunity. The upside price objective would be .6950, or above. Technical support, for which to place a protective sell stop just below, is located at .6500. IMPORTANT NOTE: I am not a futures broker and do not manage any trading accounts other than my own personal account. It is my goal to point out to you potential trading opportunities. However, it is up to you to: (1) decide when and if you want to initiate any trades and (2) determine the size of any trades you may initiate. Any trades I discuss are hypothetical in nature. Here is what the Commodity Futures Trading Commission (CFTC) has said about futures trading (and I agree 100%): Trading commodity futures and options is not for everyone. IT IS A VOLATILE, COMPLEX AND RISKY BUSINESS. Before you invest any money in futures or options contracts, you should consider your financial experience, goals and financial resources, and know how much you can afford to lose above and beyond your initial payment to a broker. You should understand commodity futures and options contracts and your obligations in entering into those contracts. You should understand your exposure to risk and other aspects of trading by thoroughly reviewing the risk disclosure documents your broker is required to give you. On the date of publication, Jim Wyckoff did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
6 hours ago
- Business
- Yahoo
Cogent Communications Holdings, Inc. (CCOI): A Bull Case Theory
We came across a bullish thesis on Cogent Communications Holdings, Inc. on Stock Analysis Compilation's Substack. In this article, we will summarize the bulls' thesis on CCOI. Cogent Communications Holdings, Inc.'s share was trading at $47.92 as of July 21st. CCOI's trailing and forward P/E were 94.04 and 5.00k, respectively according to Yahoo Finance. A high-speed internet connection providing fast data rates to customers. Cogent Communications Inc. is positioned for meaningful upside as its wavelength circuit build-out accelerates, even as investor sentiment remains weighed down by the protracted Sprint wireline integration. The company's shares have struggled after several quarters of earnings misses, with revenue yet to inflect and integration efforts still absorbing operating expenses, despite management achieving the targeted $220 million in cost savings. Beneath these near-term headwinds, Cogent's wavelength activation pipeline is gaining traction, with a backlog of 3,433 orders and a unique capability to bring circuits online in as little as two weeks, a stark advantage over competitors such as Lumen and Zayo, who typically require three to nine months. This rapid deployment should translate into share gains as installations scale, with management targeting a steady pace of approximately 500 activations per month by year-end. With average revenue per unit around $1,930 and incremental EBITDA margins exceeding 90% due to minimal variable costs, the company could generate more than $100 million in incremental cash flow annually once fully ramped. While near-term results remain clouded by integration-related expenses and delayed revenue contributions, the backlog conversion offers a clear path to meaningful cash flow growth and a rerating of the stock. Should the expected installations and resulting cash flow not materialize in the coming quarters, an exit would be warranted, but for now, the market's fixation on integration challenges leaves significant upside as Cogent leverages its operational speed to expand wavelength scale and unlock high-margin growth. Previously, we covered a bullish thesis on Cogent Communications Holdings, Inc. (CCOI) by Aaron Chan in January 2025, highlighting its transformative ROADM-enabled wavelength network and growth potential. The stock has depreciated ~34% since, as Sprint integration delays deferred revenue inflection. The thesis holds as backlog momentum builds. Stock Analysis Compilation shares a similar view, stressing near-term backlog conversion and cash flow upside. Cogent Communications Holdings, Inc. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 30 hedge fund portfolios held CCOI at the end of the first quarter which was 29 in the previous quarter. While we acknowledge the potential of CCOI as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Business
- Yahoo
Brookfield Asset Management Ltd. (BAM): A Bull Case Theory
We came across a bullish thesis on Brookfield Asset Management Ltd. on Stock Analysis Compilation's Substack. In this article, we will summarize the bulls' thesis on BAM. Brookfield Asset Management Ltd.'s share was trading at $60.19 as of July 21st. BAM's trailing and forward P/E were 44.26 and 42.55, respectively according to Yahoo Finance. Jim Cramer Says GE Vernova (GEV) Has 'Four Secular Trends Going for It' Brookfield Corporation delivered another strong quarter, with distributable earnings rising 27% to $1.55 billion, supported by record fee-related earnings of $698 million at a 57% margin and fee-bearing capital reaching $549 billion. Management successfully closed two $16 billion flagship funds and secured $25 billion of total commitments, further expanding its base of stable, compounding fees that are resilient to exit market cycles. The company also agreed to acquire a majority stake in Angel Oak, an $18 billion mortgage credit platform, launching a new lending strategy that adds to its growing insurance and operating platforms. Insurance operations generated $430 million in earnings on $133 billion of assets, driven by $4 billion in new annuity sales and a 5.7% portfolio yield, which remains 180 basis points above the cost of funds. Beyond the quarter, CEO Bruce Flatt underscored Brookfield's alignment with three structural growth drivers—digitization, decarbonization, and deglobalization—where investable assets have multiplied dramatically over the past two decades, creating deepening opportunity sets that match the firm's capabilities. Critics often highlight Brookfield's complexity, occasionally attracting short-seller scrutiny, but management views its multi-layered structure as a strategic advantage, enabling seamless capital allocation across listed partnerships, private funds, and insurance balance sheets to maximize risk-adjusted returns and capitalize on markets that reward asset-light managers with premium valuations. This disciplined flexibility, which has driven approximately 19% annual capital compounding over three decades, continues to reinforce Brookfield's positioning as a leading alternative asset manager with enduring growth potential and multiple levers for sustained value creation. Previously, we covered a bullish thesis on Brookfield Asset Management Ltd. (BAM) by Soren Peterson in February 2025, which highlighted the company's positioning to benefit from AI-driven infrastructure, credit expansion, and efficient capital-raising within the Brookfield ecosystem. The company's stock price has depreciated approximately by 0.82% since our coverage, though the thesis remains intact. Stock Analysis Compilation shares a similar view but emphasizes recent record earnings and structural tailwinds driving long-term growth. Brookfield Asset Management Ltd. is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 38 hedge fund portfolios held BAM at the end of the first quarter which was 21 in the previous quarter. While we acknowledge the potential of BAM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
Yahoo
7 hours ago
- Business
- Yahoo
Abbott Laboratories (ABT): A Bull Case Theory
We came across a bullish thesis on Abbott Laboratories on r/ValueInvesting subreddit by anonymous_sheep1. In this article, we will summarize the bulls' thesis on ABT. Abbott Laboratories' share was trading at $120.51 as of July 17th. ABT's trailing and forward P/E were 15.12 and 23.42, respectively, according to Yahoo Finance. A grocery store shelf lined with the company's nutritional products. Abbott Laboratories (ABT) delivered quarterly results that reaffirmed management's guidance and highlighted solid momentum across its devices and nutrition segments heading into the second half of the year. A quick valuation exercise using a 5.74% five-year FCF CAGR, derived from 6% operating cash flow growth and 2% capex growth, indicates attractive return potential at the current $120.51 share price. Applying a 7.39% WACC and historical P/FCF averages of ~31.5x yields DCF-based target prices of $143.42 (bull, 35x), $130.21 (base, 31.5x), and $109.45 (bear, 26x), translating to an 8% base-case upside by year-end 2025. Corresponding 5-year IRRs stand at 12% (bull), 10% (base), and 5% (bear), implying that even in a conservative scenario, ABT offers mid-single-digit annualized returns, while a favorable multiple re-rating could push IRRs into double digits. The stock is not deeply undervalued but remains fairly priced for a business of ABT's quality, underpinned by a wide moat, durable free cash flow generation, and pricing power. With reaffirmed guidance and a resilient operating profile, ABT continues to represent a steady compounder rather than a rapid upside story. The company's track record of execution and its leadership across key healthcare categories support the patient case, long-term ownership. For investors seeking stable compounding with limited downside and double-digit IRR potential in an optimistic case, initiating a position at current levels offers a favorable risk/reward balance, aligning with a Buffett-style strategy of holding high-quality businesses over extended horizons. Previously, we covered a bullish thesis on Medtronic plc (MDT) by Investing Intel's Substack in May 2025, which highlighted strong results and a planned diabetes unit spin-off to unlock value. The stock has appreciated about 10.96% since execution gained traction. The thesis still stands as portfolio focus, and the spin-off remains a key driver. anonymous_sheep1 shares a similar view on Abbott Laboratories, emphasizing ABT's steady compounding potential and durable FCF generation. Abbott Laboratories is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 70 hedge fund portfolios held ABT at the end of the first quarter which was 66 in the previous quarter. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
